ArticlePharmaceutics2023

Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.